Freedom of Information request on the total number of individual inactivated influenza vaccines that have been administered to the UK population since the first reported ADR on 09/10/1963 until 08/04/21 (FOI 21-700)
Published 13 August 2021
© Crown copyright 2021
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-28-june-2021/freedom-of-information-request-on-the-total-number-of-individual-inactivated-influenza-vaccines-that-have-been-administered-to-the-uk-population-since
30th June 2021 FOI 21/700
Dear
Thank you for your FOI request dated 23rd June 2021, where you requested the following information:
“The total number of individual Inactivated influenza vaccines that have been administered to the UK Population since the first reported ADR on 09/10/1963 up until the date of 08/04/21
The total number of individual Live attenuated influenza vaccine that have been administered to the UK Population since the first reported ADR on 10/10/2012 up until the date of 28/02/21”
I can confirm that we do not hold the information that you have requested.
You may wish to contact Public Health England at enquiries@phe.gov.uk as they may be able to provide the information you requested.
I hope the response provided is helpful, but if you are dissatisfied with the handling of your request, you have the right to ask for an internal review. Internal review requests should be submitted within two months of the date of this response; and can be addressed to this email address.
Yours sincerely,
FOI Team, Vigilance and Risk Management of Medicines Division